nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Upset stomach—Mesalazine—Crohn's disease	0.0204	0.0276	CcSEcCtD
Glycopyrrolate—Intestinal obstruction—Mesalazine—Crohn's disease	0.0196	0.0265	CcSEcCtD
Glycopyrrolate—Cystitis noninfective—Mesalazine—Crohn's disease	0.0131	0.0176	CcSEcCtD
Glycopyrrolate—Cystitis—Mesalazine—Crohn's disease	0.0129	0.0174	CcSEcCtD
Glycopyrrolate—Bladder pain—Mesalazine—Crohn's disease	0.0121	0.0163	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Mesalazine—Crohn's disease	0.0109	0.0148	CcSEcCtD
Glycopyrrolate—Malnutrition—Mercaptopurine—Crohn's disease	0.0108	0.0145	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Mesalazine—Crohn's disease	0.0102	0.0138	CcSEcCtD
Glycopyrrolate—Affect lability—Mesalazine—Crohn's disease	0.00955	0.0129	CcSEcCtD
Glycopyrrolate—Mood swings—Mesalazine—Crohn's disease	0.00919	0.0124	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0091	0.0123	CcSEcCtD
Glycopyrrolate—Dry skin—Mesalazine—Crohn's disease	0.0089	0.012	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Azathioprine—Crohn's disease	0.00883	0.0119	CcSEcCtD
Glycopyrrolate—Oedema—Mercaptopurine—Crohn's disease	0.00879	0.0119	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Mesalazine—Crohn's disease	0.00868	0.0117	CcSEcCtD
Glycopyrrolate—Skin disorder—Mercaptopurine—Crohn's disease	0.00854	0.0115	CcSEcCtD
Glycopyrrolate—Abdominal distension—Mesalazine—Crohn's disease	0.00844	0.0114	CcSEcCtD
Glycopyrrolate—Pneumonia—Azathioprine—Crohn's disease	0.00826	0.0112	CcSEcCtD
Glycopyrrolate—Infestation NOS—Azathioprine—Crohn's disease	0.00821	0.0111	CcSEcCtD
Glycopyrrolate—Infestation—Azathioprine—Crohn's disease	0.00821	0.0111	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Mesalazine—Crohn's disease	0.00804	0.0109	CcSEcCtD
Glycopyrrolate—Dysuria—Mesalazine—Crohn's disease	0.00784	0.0106	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.0078	0.0105	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00759	0.0102	CcSEcCtD
Glycopyrrolate—Pneumonia—Mesalazine—Crohn's disease	0.00752	0.0102	CcSEcCtD
Glycopyrrolate—Infestation NOS—Mesalazine—Crohn's disease	0.00748	0.0101	CcSEcCtD
Glycopyrrolate—Infestation—Mesalazine—Crohn's disease	0.00748	0.0101	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Mesalazine—Crohn's disease	0.00727	0.00982	CcSEcCtD
Glycopyrrolate—Sweating—Mesalazine—Crohn's disease	0.00717	0.00968	CcSEcCtD
Glycopyrrolate—Epistaxis—Mesalazine—Crohn's disease	0.00705	0.00953	CcSEcCtD
Glycopyrrolate—Sinusitis—Mesalazine—Crohn's disease	0.00702	0.00948	CcSEcCtD
Glycopyrrolate—Body temperature increased—Mercaptopurine—Crohn's disease	0.00695	0.00938	CcSEcCtD
Glycopyrrolate—Rhinitis—Mesalazine—Crohn's disease	0.00673	0.00909	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Azathioprine—Crohn's disease	0.00664	0.00897	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Mesalazine—Crohn's disease	0.00663	0.00895	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Mesalazine—Crohn's disease	0.0066	0.00891	CcSEcCtD
Glycopyrrolate—Urethral disorder—Mesalazine—Crohn's disease	0.00658	0.00889	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00647	0.00874	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Mesalazine—Crohn's disease	0.00623	0.00841	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Mesalazine—Crohn's disease	0.00605	0.00817	CcSEcCtD
Glycopyrrolate—Mental disorder—Mesalazine—Crohn's disease	0.00588	0.00794	CcSEcCtD
Glycopyrrolate—Erythema—Mesalazine—Crohn's disease	0.00584	0.00789	CcSEcCtD
Glycopyrrolate—Flatulence—Mesalazine—Crohn's disease	0.00576	0.00778	CcSEcCtD
Glycopyrrolate—Tension—Mesalazine—Crohn's disease	0.00574	0.00775	CcSEcCtD
Glycopyrrolate—Dysgeusia—Mesalazine—Crohn's disease	0.00572	0.00773	CcSEcCtD
Glycopyrrolate—Nervousness—Mesalazine—Crohn's disease	0.00568	0.00767	CcSEcCtD
Glycopyrrolate—Vomiting—Mercaptopurine—Crohn's disease	0.00559	0.00755	CcSEcCtD
Glycopyrrolate—Rash—Mercaptopurine—Crohn's disease	0.00554	0.00748	CcSEcCtD
Glycopyrrolate—Dermatitis—Mercaptopurine—Crohn's disease	0.00554	0.00748	CcSEcCtD
Glycopyrrolate—Vision blurred—Mesalazine—Crohn's disease	0.00551	0.00744	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00542	0.00733	CcSEcCtD
Glycopyrrolate—Nausea—Mercaptopurine—Crohn's disease	0.00522	0.00705	CcSEcCtD
Glycopyrrolate—Infection—Azathioprine—Crohn's disease	0.0052	0.00703	CcSEcCtD
Glycopyrrolate—Palpitations—Mesalazine—Crohn's disease	0.00516	0.00698	CcSEcCtD
Glycopyrrolate—Skin disorder—Azathioprine—Crohn's disease	0.00509	0.00687	CcSEcCtD
Glycopyrrolate—Affect lability—Prednisone—Crohn's disease	0.00505	0.00683	CcSEcCtD
Glycopyrrolate—Hypertension—Mesalazine—Crohn's disease	0.00505	0.00681	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00494	0.00667	CcSEcCtD
Glycopyrrolate—Irritability—Prednisone—Crohn's disease	0.0049	0.00662	CcSEcCtD
Glycopyrrolate—Hypotension—Azathioprine—Crohn's disease	0.00489	0.00661	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Prednisone—Crohn's disease	0.00488	0.00659	CcSEcCtD
Glycopyrrolate—Dry mouth—Mesalazine—Crohn's disease	0.00487	0.00657	CcSEcCtD
Glycopyrrolate—Mood swings—Prednisone—Crohn's disease	0.00486	0.00657	CcSEcCtD
Glycopyrrolate—Confusional state—Mesalazine—Crohn's disease	0.00481	0.0065	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Mesalazine—Crohn's disease	0.00477	0.00644	CcSEcCtD
Glycopyrrolate—Oedema—Mesalazine—Crohn's disease	0.00477	0.00644	CcSEcCtD
Glycopyrrolate—Infection—Mesalazine—Crohn's disease	0.00474	0.0064	CcSEcCtD
Glycopyrrolate—Dry skin—Prednisone—Crohn's disease	0.00471	0.00636	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Mesalazine—Crohn's disease	0.00468	0.00632	CcSEcCtD
Glycopyrrolate—Tachycardia—Mesalazine—Crohn's disease	0.00466	0.00629	CcSEcCtD
Glycopyrrolate—Skin disorder—Mesalazine—Crohn's disease	0.00463	0.00626	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Mesalazine—Crohn's disease	0.00461	0.00623	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00452	0.00611	CcSEcCtD
Glycopyrrolate—Abdominal distension—Prednisone—Crohn's disease	0.00447	0.00603	CcSEcCtD
Glycopyrrolate—Hypotension—Mesalazine—Crohn's disease	0.00446	0.00602	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Azathioprine—Crohn's disease	0.00432	0.00583	CcSEcCtD
Glycopyrrolate—Insomnia—Mesalazine—Crohn's disease	0.00431	0.00583	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00428	0.00578	CcSEcCtD
Glycopyrrolate—Somnolence—Mesalazine—Crohn's disease	0.00424	0.00573	CcSEcCtD
Glycopyrrolate—Dyspepsia—Mesalazine—Crohn's disease	0.0042	0.00567	CcSEcCtD
Glycopyrrolate—Body temperature increased—Azathioprine—Crohn's disease	0.00414	0.00559	CcSEcCtD
Glycopyrrolate—Abdominal pain—Azathioprine—Crohn's disease	0.00414	0.00559	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00412	0.00556	CcSEcCtD
Glycopyrrolate—Fatigue—Mesalazine—Crohn's disease	0.00411	0.00555	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Prednisone—Crohn's disease	0.00409	0.00552	CcSEcCtD
Glycopyrrolate—Pain—Mesalazine—Crohn's disease	0.00408	0.00551	CcSEcCtD
Glycopyrrolate—Constipation—Mesalazine—Crohn's disease	0.00408	0.00551	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Prednisone—Crohn's disease	0.004	0.00541	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Mesalazine—Crohn's disease	0.00393	0.00531	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Mesalazine—Crohn's disease	0.0039	0.00527	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Azathioprine—Crohn's disease	0.00386	0.00521	CcSEcCtD
Glycopyrrolate—Urticaria—Mesalazine—Crohn's disease	0.00379	0.00512	CcSEcCtD
Glycopyrrolate—Abdominal pain—Mesalazine—Crohn's disease	0.00377	0.00509	CcSEcCtD
Glycopyrrolate—Body temperature increased—Mesalazine—Crohn's disease	0.00377	0.00509	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Mesalazine—Crohn's disease	0.00351	0.00475	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Prednisone—Crohn's disease	0.00349	0.00471	CcSEcCtD
Glycopyrrolate—Dizziness—Azathioprine—Crohn's disease	0.00346	0.00468	CcSEcCtD
Glycopyrrolate—Asthenia—Mesalazine—Crohn's disease	0.00342	0.00462	CcSEcCtD
Glycopyrrolate—Pruritus—Mesalazine—Crohn's disease	0.00337	0.00456	CcSEcCtD
Glycopyrrolate—Vomiting—Azathioprine—Crohn's disease	0.00333	0.0045	CcSEcCtD
Glycopyrrolate—Rash—Azathioprine—Crohn's disease	0.0033	0.00446	CcSEcCtD
Glycopyrrolate—Dermatitis—Azathioprine—Crohn's disease	0.0033	0.00445	CcSEcCtD
Glycopyrrolate—Flushing—Prednisone—Crohn's disease	0.0033	0.00445	CcSEcCtD
Glycopyrrolate—Headache—Azathioprine—Crohn's disease	0.00328	0.00443	CcSEcCtD
Glycopyrrolate—Dizziness—Mesalazine—Crohn's disease	0.00315	0.00426	CcSEcCtD
Glycopyrrolate—Mental disorder—Prednisone—Crohn's disease	0.00311	0.0042	CcSEcCtD
Glycopyrrolate—Nausea—Azathioprine—Crohn's disease	0.00311	0.0042	CcSEcCtD
Glycopyrrolate—Malnutrition—Prednisone—Crohn's disease	0.00309	0.00418	CcSEcCtD
Glycopyrrolate—Erythema—Prednisone—Crohn's disease	0.00309	0.00418	CcSEcCtD
Glycopyrrolate—Vomiting—Mesalazine—Crohn's disease	0.00303	0.0041	CcSEcCtD
Glycopyrrolate—Rash—Mesalazine—Crohn's disease	0.00301	0.00406	CcSEcCtD
Glycopyrrolate—Dermatitis—Mesalazine—Crohn's disease	0.003	0.00406	CcSEcCtD
Glycopyrrolate—Headache—Mesalazine—Crohn's disease	0.00299	0.00404	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisone—Crohn's disease	0.00291	0.00394	CcSEcCtD
Glycopyrrolate—Agitation—Prednisone—Crohn's disease	0.00284	0.00384	CcSEcCtD
Glycopyrrolate—Nausea—Mesalazine—Crohn's disease	0.00283	0.00383	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisone—Crohn's disease	0.00268	0.00362	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisone—Crohn's disease	0.00267	0.00361	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00261	0.00353	CcSEcCtD
Glycopyrrolate—Oedema—Prednisone—Crohn's disease	0.00252	0.00341	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisone—Crohn's disease	0.00252	0.00341	CcSEcCtD
Glycopyrrolate—Infection—Prednisone—Crohn's disease	0.00251	0.00339	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Prednisone—Crohn's disease	0.00247	0.00334	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisone—Crohn's disease	0.00246	0.00333	CcSEcCtD
Glycopyrrolate—Skin disorder—Prednisone—Crohn's disease	0.00245	0.00331	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisone—Crohn's disease	0.00244	0.00329	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisone—Crohn's disease	0.00228	0.00308	CcSEcCtD
Glycopyrrolate—Dyspepsia—Prednisone—Crohn's disease	0.00222	0.003	CcSEcCtD
Glycopyrrolate—Fatigue—Prednisone—Crohn's disease	0.00218	0.00294	CcSEcCtD
Glycopyrrolate—Constipation—Prednisone—Crohn's disease	0.00216	0.00291	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisone—Crohn's disease	0.00208	0.00281	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Prednisone—Crohn's disease	0.00206	0.00279	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisone—Crohn's disease	0.002	0.00271	CcSEcCtD
Glycopyrrolate—Abdominal pain—Prednisone—Crohn's disease	0.00199	0.00269	CcSEcCtD
Glycopyrrolate—Body temperature increased—Prednisone—Crohn's disease	0.00199	0.00269	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisone—Crohn's disease	0.00186	0.00251	CcSEcCtD
Glycopyrrolate—Asthenia—Prednisone—Crohn's disease	0.00181	0.00245	CcSEcCtD
Glycopyrrolate—Pruritus—Prednisone—Crohn's disease	0.00179	0.00241	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisone—Crohn's disease	0.00167	0.00225	CcSEcCtD
Glycopyrrolate—Vomiting—Prednisone—Crohn's disease	0.0016	0.00217	CcSEcCtD
Glycopyrrolate—Rash—Prednisone—Crohn's disease	0.00159	0.00215	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisone—Crohn's disease	0.00159	0.00215	CcSEcCtD
Glycopyrrolate—Headache—Prednisone—Crohn's disease	0.00158	0.00214	CcSEcCtD
Glycopyrrolate—Nausea—Prednisone—Crohn's disease	0.0015	0.00202	CcSEcCtD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR9—Crohn's disease	0.000763	0.00294	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000758	0.00292	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—GPR65—Crohn's disease	0.000748	0.00288	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MLN—Crohn's disease	0.000742	0.00286	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MLN—Crohn's disease	0.00074	0.00285	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MLN—Crohn's disease	0.000732	0.00282	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR9—Crohn's disease	0.00073	0.00281	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—GPR65—Crohn's disease	0.000709	0.00273	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ACKR2—Crohn's disease	0.000686	0.00264	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—GPR65—Crohn's disease	0.000679	0.00262	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCR6—Crohn's disease	0.000664	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCR6—Crohn's disease	0.000662	0.00255	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ACKR2—Crohn's disease	0.000657	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCR6—Crohn's disease	0.000655	0.00252	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MLN—Crohn's disease	0.00065	0.0025	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MLN—Crohn's disease	0.000623	0.0024	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000619	0.00238	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TAGAP—Crohn's disease	0.000595	0.00229	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00059	0.00227	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000584	0.00225	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—PTGER4—Crohn's disease	0.000583	0.00224	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—PTGER4—Crohn's disease	0.000577	0.00222	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TAGAP—Crohn's disease	0.000569	0.00219	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000566	0.00218	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR9—Crohn's disease	0.000565	0.00218	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR9—Crohn's disease	0.000559	0.00215	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCR6—Crohn's disease	0.000556	0.00214	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCR6—Crohn's disease	0.000533	0.00205	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000527	0.00203	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—GPR65—Crohn's disease	0.000525	0.00202	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000524	0.00202	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—GPR65—Crohn's disease	0.00052	0.002	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RSPO3—Crohn's disease	0.00052	0.002	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR9—Crohn's disease	0.000514	0.00198	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR9—Crohn's disease	0.000513	0.00198	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR9—Crohn's disease	0.000508	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR6—Crohn's disease	0.000505	0.00195	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RSPO3—Crohn's disease	0.000498	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SEL1L—Crohn's disease	0.000493	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PTGER4—Crohn's disease	0.00049	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000484	0.00187	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR6—Crohn's disease	0.000484	0.00186	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000478	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PLA2G4F—Crohn's disease	0.000478	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—GPR65—Crohn's disease	0.000477	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—GPR65—Crohn's disease	0.000472	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SEL1L—Crohn's disease	0.000472	0.00182	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PTGER4—Crohn's disease	0.000469	0.00181	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000464	0.00179	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000462	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ACKR2—Crohn's disease	0.000461	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ACKR2—Crohn's disease	0.000456	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR9—Crohn's disease	0.000451	0.00174	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PTGER4—Crohn's disease	0.000445	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MLN—Crohn's disease	0.000438	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MLN—Crohn's disease	0.000437	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000436	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.000434	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MLN—Crohn's disease	0.000433	0.00167	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR9—Crohn's disease	0.000432	0.00166	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PTGER4—Crohn's disease	0.000426	0.00164	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—GPR65—Crohn's disease	0.000419	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL3—Crohn's disease	0.000417	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000417	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000416	0.0016	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.000414	0.0016	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTMR3—Crohn's disease	0.000406	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000404	0.00155	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—GPR65—Crohn's disease	0.000401	0.00155	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000401	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TAGAP—Crohn's disease	0.0004	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL3—Crohn's disease	0.0004	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000399	0.00154	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TAGAP—Crohn's disease	0.000396	0.00152	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000386	0.00149	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL3—Crohn's disease	0.000379	0.00146	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000375	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR6—Crohn's disease	0.000374	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR6—Crohn's disease	0.00037	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000366	0.00141	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL3—Crohn's disease	0.000363	0.0014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—RASGRP1—Crohn's disease	0.000351	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RSPO3—Crohn's disease	0.00035	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RSPO3—Crohn's disease	0.000349	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000349	0.00134	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RSPO3—Crohn's disease	0.000346	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000341	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR6—Crohn's disease	0.00034	0.00131	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000337	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR6—Crohn's disease	0.000336	0.0013	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SEL1L—Crohn's disease	0.000332	0.00128	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SEL1L—Crohn's disease	0.000331	0.00128	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.00033	0.00127	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PTGER4—Crohn's disease	0.000329	0.00127	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SEL1L—Crohn's disease	0.000328	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PTGER4—Crohn's disease	0.000326	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CXCL8—Crohn's disease	0.000317	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—FADS1—Crohn's disease	0.000317	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CXCL8—Crohn's disease	0.000304	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR9—Crohn's disease	0.000304	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR9—Crohn's disease	0.000303	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000303	0.00117	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.0003	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR9—Crohn's disease	0.0003	0.00116	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PTGER4—Crohn's disease	0.000299	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR6—Crohn's disease	0.000298	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GPX4—Crohn's disease	0.000296	0.00114	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PTGER4—Crohn's disease	0.000296	0.00114	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000292	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GCKR—Crohn's disease	0.000286	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR6—Crohn's disease	0.000286	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GPR65—Crohn's disease	0.000282	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GPR65—Crohn's disease	0.000282	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000281	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000281	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL3—Crohn's disease	0.00028	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00028	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL2RA—Crohn's disease	0.00028	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GPR65—Crohn's disease	0.000279	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL3—Crohn's disease	0.000278	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000277	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000272	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000272	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000271	0.00105	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RBX1—Crohn's disease	0.00027	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000269	0.00103	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL2RA—Crohn's disease	0.000265	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTGER4—Crohn's disease	0.000263	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RBX1—Crohn's disease	0.000259	0.000996	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL3—Crohn's disease	0.000255	0.000984	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL3—Crohn's disease	0.000255	0.000981	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL2RA—Crohn's disease	0.000254	0.000979	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL3—Crohn's disease	0.000252	0.000972	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTGER4—Crohn's disease	0.000252	0.00097	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000247	0.000952	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—RASGRP1—Crohn's disease	0.000246	0.000949	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000244	0.00094	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—UBE2D1—Crohn's disease	0.000237	0.000912	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RIPK2—Crohn's disease	0.00023	0.000884	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—UBE2D1—Crohn's disease	0.000227	0.000873	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—IL6—Crohn's disease	0.000225	0.000867	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL3—Crohn's disease	0.000224	0.000862	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RIPK2—Crohn's disease	0.00022	0.000847	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RASGRP1—Crohn's disease	0.000216	0.000834	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL3—Crohn's disease	0.000214	0.000826	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000214	0.000824	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CXCL8—Crohn's disease	0.000213	0.000822	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000213	0.000821	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000212	0.000818	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CXCL8—Crohn's disease	0.000211	0.000814	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RASGRP1—Crohn's disease	0.000207	0.000799	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR6—Crohn's disease	0.000201	0.000775	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR6—Crohn's disease	0.000201	0.000773	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR6—Crohn's disease	0.000199	0.000765	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000197	0.000759	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—JAK2—Crohn's disease	0.000196	0.000757	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL2RA—Crohn's disease	0.000196	0.000757	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SOCS1—Crohn's disease	0.000196	0.000756	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000195	0.00075	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—JAK2—Crohn's disease	0.000188	0.000725	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SOCS1—Crohn's disease	0.000188	0.000724	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—TYK2—Crohn's disease	0.000187	0.00072	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RBX1—Crohn's disease	0.000182	0.000701	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RBX1—Crohn's disease	0.000181	0.000699	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RBX1—Crohn's disease	0.00018	0.000692	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000179	0.000691	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—TYK2—Crohn's disease	0.000179	0.00069	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000179	0.00069	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2RA—Crohn's disease	0.000178	0.000687	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—JAK2—Crohn's disease	0.000178	0.000687	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000177	0.000683	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2RA—Crohn's disease	0.000177	0.000681	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTGER4—Crohn's disease	0.000177	0.00068	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTGER4—Crohn's disease	0.000175	0.000674	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000172	0.000662	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—JAK2—Crohn's disease	0.000171	0.000658	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SMAD3—Crohn's disease	0.000169	0.000652	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CXCL8—Crohn's disease	0.000163	0.000627	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SMAD3—Crohn's disease	0.000162	0.000625	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.00016	0.000615	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—UBE2D1—Crohn's disease	0.000159	0.000613	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—UBE2D1—Crohn's disease	0.000158	0.000607	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2RA—Crohn's disease	0.000157	0.000604	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CXCL8—Crohn's disease	0.000156	0.000601	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000155	0.000596	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RIPK2—Crohn's disease	0.000154	0.000594	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RIPK2—Crohn's disease	0.000153	0.000589	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL3—Crohn's disease	0.000151	0.000581	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL3—Crohn's disease	0.00015	0.00058	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2RA—Crohn's disease	0.00015	0.000578	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL3—Crohn's disease	0.000149	0.000574	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RASGRP1—Crohn's disease	0.000146	0.000562	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RASGRP1—Crohn's disease	0.000146	0.000561	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RASGRP1—Crohn's disease	0.000144	0.000555	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	0.000132	0.00051	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	0.000132	0.00051	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	0.000132	0.000509	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	0.000132	0.000508	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	0.000131	0.000504	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	0.000131	0.000503	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	0.000126	0.000486	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	0.000126	0.000484	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	0.000124	0.00048	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000121	0.000466	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	0.000121	0.000464	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	0.00012	0.000463	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	0.00012	0.000462	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000119	0.00046	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	0.000119	0.000457	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	0.000114	0.00044	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	0.000114	0.000439	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	0.000113	0.000434	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TYK2—Crohn's disease	0.00011	0.000426	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	0.00011	0.000423	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	0.000109	0.000422	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	0.000108	0.000418	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TYK2—Crohn's disease	0.000106	0.000408	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	0.000106	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—JAK2—Crohn's disease	0.000105	0.000406	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	0.000105	0.000406	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	0.000104	0.000402	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—JAK2—Crohn's disease	0.000101	0.000389	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	9.62e-05	0.000371	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	9.21e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—Crohn's disease	9.15e-05	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—Crohn's disease	9.11e-05	0.000351	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—Crohn's disease	8.76e-05	0.000337	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—Crohn's disease	7.97e-05	0.000307	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—Crohn's disease	7.74e-05	0.000298	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TYK2—Crohn's disease	7.45e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TYK2—Crohn's disease	7.43e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—Crohn's disease	7.41e-05	0.000285	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TYK2—Crohn's disease	7.35e-05	0.000283	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—JAK2—Crohn's disease	7.11e-05	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—JAK2—Crohn's disease	7.08e-05	0.000273	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—JAK2—Crohn's disease	7.01e-05	0.00027	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	6.49e-05	0.00025	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	6.46e-05	0.000249	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	6.4e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—Crohn's disease	6.17e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—Crohn's disease	6.15e-05	0.000237	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—Crohn's disease	6.09e-05	0.000235	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—Crohn's disease	5.4e-05	0.000208	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—Crohn's disease	5.22e-05	0.000201	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—Crohn's disease	5.2e-05	0.0002	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—Crohn's disease	5.17e-05	0.000199	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—Crohn's disease	5.15e-05	0.000198	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—Crohn's disease	3.64e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—Crohn's disease	3.63e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—Crohn's disease	3.6e-05	0.000139	CbGpPWpGaD
